Clinical Trial Update: Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT [NA]

View source ↗

Summary

A clinical trial evaluating a mycobiome-supported diet to reduce GI toxicity during autologous stem cell transplant for multiple myeloma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Autologous Transplant, Myeloma | NA | Status: WITHDRAWN